Sodium Hyaluronate

Sodium hyaluronate is a purified form of hyaluronic acid widely used in viscosupplementation therapy for osteoarthritis, particularly of the knee joint. It acts as a viscoelastic substance that restores the natural lubricating and shock-absorbing properties of synovial fluid. In degenerative joint conditions where the quality of synovial fluid declines, sodium hyaluronate injections help improve joint movement and reduce pain during weight-bearing activities.

Physiologically, hyaluronic acid is an essential component of healthy joint fluid and cartilage matrix. In osteoarthritis, its concentration and molecular weight decrease, leading to increased friction, cartilage wear, and joint stiffness. Intra-articular sodium hyaluronate supplementation helps restore joint biomechanics by enhancing lubrication, improving shock absorption, and possibly exerting mild anti-inflammatory effects within the joint space.

Clinically, sodium hyaluronate injections are administered directly into the affected joint by a trained healthcare professional. The therapy is often considered in patients who have persistent knee osteoarthritis symptoms despite oral medications and lifestyle measures. Many patients experience gradual improvement in joint comfort, reduced stiffness, and better functional mobility over several weeks following the injection series.

The treatment is generally well tolerated, with mild transient injection-site discomfort being the most common side effect. Proper patient selection and sterile injection technique are important for optimal outcomes. When used appropriately, sodium hyaluronate remains an important non-surgical option for improving joint function and delaying progression of symptomatic osteoarthritis.